![William Rice](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Rice
Vorstandsvorsitzender bei
APTOSE BIOSCIENCES INC.
Vermögen: 10 131 $ am 31.05.2026
Profil
William G.
Rice was the founder of Achillion Pharmaceuticals, Inc., founded in 1998, where the titles held included President, Chief Executive Officer & Director from 1998 to 2003.
Current jobs include Chairman, President & Chief Executive Officer at Aptose Biosciences, Inc. since 2013, and Chairman at Cylene Pharmaceuticals, Inc. since 2013, with employment starting in 2003.
Former jobs include Independent Director at Oncolytics Biotech, Inc. from 2015 to 2021, Member-Pediatric Hematology & Oncology at Emory University School of Medicine from 1989 to 1992, and Senior Scientist & Head-Drug Mechanism Lab at Frederick National Laboratory For Cancer Research from 1992 to 1998.
Education includes a doctorate degree from Emory University, conferred in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
APTOSE BIOSCIENCES INC. 0,24 % | 23.02.2026 | 6 140 ( 0,24 % ) | 10 131 $ | 31.05.2026 |
Aktive Positionen von William Rice
| Unternehmen | Position | Beginn |
|---|---|---|
| APTOSE BIOSCIENCES INC. | Vorstandsvorsitzender | 28.10.2013 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Vorsitzender | 28.09.2010 |
Ehemalige bekannte Positionen von William Rice
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Direktor/Vorstandsmitglied | 01.01.2021 |
| ACHILLION PHARMACEUTICALS, INC. | Gründer | 01.08.2003 |
Frederick National Laboratory For Cancer Research
 Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology The Frederick National Laboratory for Cancer Research (FNLCR), operated by Leidos Biomedical Research, Inc. for the National Cancer Institute, is a government-affiliated biomedical research institution dedicated to advancing cancer, AIDS, and infectious disease research. The company is based in Frederick and ultimately controlled by the Government of the United States of America. It offers scientific programs, specialized laboratories, and technological platforms such as cryo-electron microscopy, nanotechnology characterization, molecular diagnostics, protein expression, and laboratory animal sciences. FNLCR develops scientific standards and reference materials to enhance research quality and data reliability, and its initiatives include the RAS Initiative targeting cancer-driving genes, vaccine development programs, precision medicine trials for blood cancers, and viral oncology research. The laboratory supports investigators with scientific expertise, technical services, user facilities, and training modules, and fosters collaboration across government, academia, and industry through technology transfer, licensing, and partnerships. FNLCR also engages in community outreach, workforce development, and diversity initiatives. | Corporate Officer/Principal | 01.01.1998 |
Emory University School of Medicine
 Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1992 |
Ausbildung von William Rice
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frederick National Laboratory For Cancer Research
Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology The Frederick National Laboratory for Cancer Research (FNLCR), operated by Leidos Biomedical Research, Inc. for the National Cancer Institute, is a government-affiliated biomedical research institution dedicated to advancing cancer, AIDS, and infectious disease research. The company is based in Frederick and ultimately controlled by the Government of the United States of America. It offers scientific programs, specialized laboratories, and technological platforms such as cryo-electron microscopy, nanotechnology characterization, molecular diagnostics, protein expression, and laboratory animal sciences. FNLCR develops scientific standards and reference materials to enhance research quality and data reliability, and its initiatives include the RAS Initiative targeting cancer-driving genes, vaccine development programs, precision medicine trials for blood cancers, and viral oncology research. The laboratory supports investigators with scientific expertise, technical services, user facilities, and training modules, and fosters collaboration across government, academia, and industry through technology transfer, licensing, and partnerships. FNLCR also engages in community outreach, workforce development, and diversity initiatives. | Electronic Technology |
